GUARNERI, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 2.316
NA - Nord America 1.174
EU - Europa 801
SA - Sud America 523
AF - Africa 48
OC - Oceania 6
Totale 4.868
Nazione #
US - Stati Uniti d'America 1.121
SG - Singapore 956
CN - Cina 509
IT - Italia 501
BR - Brasile 433
HK - Hong Kong 317
VN - Vietnam 193
NL - Olanda 127
KR - Corea 119
IN - India 57
FR - Francia 37
JP - Giappone 35
AR - Argentina 33
GB - Regno Unito 31
ID - Indonesia 27
BD - Bangladesh 22
DE - Germania 21
FI - Finlandia 21
MX - Messico 21
IL - Israele 18
EC - Ecuador 17
CA - Canada 15
ZA - Sudafrica 13
VE - Venezuela 12
ES - Italia 11
CO - Colombia 10
IQ - Iraq 10
MA - Marocco 9
TR - Turchia 9
PL - Polonia 8
SA - Arabia Saudita 8
CL - Cile 7
EG - Egitto 7
AT - Austria 5
RU - Federazione Russa 5
UA - Ucraina 5
AL - Albania 4
AU - Australia 4
CH - Svizzera 4
JO - Giordania 4
NP - Nepal 4
PE - Perù 4
PS - Palestinian Territory 4
PY - Paraguay 4
TH - Thailandia 4
TN - Tunisia 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
ET - Etiopia 2
LT - Lituania 2
LU - Lussemburgo 2
MY - Malesia 2
PH - Filippine 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CU - Cuba 1
DJ - Gibuti 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
SV - El Salvador 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 4.868
Città #
Santa Clara 654
Singapore 613
Hong Kong 316
Hefei 294
Seoul 118
Beijing 92
Ho Chi Minh City 68
Ashburn 64
Milan 57
Hanoi 44
São Paulo 44
San Jose 41
Rome 38
Los Angeles 32
Rio de Janeiro 25
Dallas 24
Helsinki 18
Haiphong 17
Minamishinagawa 17
Mumbai 17
Turin 17
Bengaluru 16
Naples 16
New York 16
Bologna 15
Florence 15
Genoa 12
Bitonto 11
Minamimotomachi 11
Buffalo 10
Guayaquil 10
Reggio Calabria 10
Palermo 9
Biên Hòa 8
Brooklyn 8
St Louis 8
Belo Horizonte 7
Frankfurt am Main 7
Monmouth Junction 7
Orem 7
Tokyo 7
Chicago 6
Dhaka 6
Guarulhos 6
Jakarta 6
Manchester 6
Montreal 6
Phoenix 6
Riyadh 6
Boston 5
Brasília 5
Catania 5
Fortaleza 5
Houston 5
Johannesburg 5
Livorno 5
Messina 5
Padua 5
Querétaro 5
Reggio Emilia 5
Thái Nguyên 5
Vicenza 5
Warsaw 5
Amman 4
Ankara 4
Asunción 4
Atlanta 4
Bangkok 4
Brescia 4
Cape Town 4
Cascina 4
London 4
Mexico City 4
New Delhi 4
Nha Trang 4
Nova Iguaçu 4
Novi Ligure 4
Nuremberg 4
Poplar 4
Porto Alegre 4
Ramallah 4
Recife 4
Ribeirão Preto 4
Salvador 4
Tashkent 4
Volta Redonda 4
Zurich 4
Abidjan 3
Amsterdam 3
Baghdad 3
Barcellona Pozzo di Gotto 3
Barueri 3
Betim 3
Bexley 3
Botucatu 3
Campinas 3
Can Tho 3
Caracas 3
Cavallino 3
Caxias do Sul 3
Totale 3.073
Nome #
Analisi farmacologiche di nuovi sistemi nanoparticellari per il rilascio del blu di metilene con potenziali effetti nelle malattie neurodegenerative 450
Neuroanatomia - Un approccio semplice e comprensibile 90
Formulations used to treat ocular diseases comprising e.g. macular edema, uveitis, comprise active ingredients incorporated in nanostructured systems 82
Variazioni dell'espressione di VAPB e dei suoi prodotti di clivaggio nei pazienti con Sclerosi Laterale Amiotrofica 81
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse. 69
DBI (DIAZEPAM BINDING INHIBITOR) - THE PRECURSOR OF A FAMILY OF ENDOGENOUS MODULATORS OF GABA-A RECEPTOR FUNCTION - HISTORY, PERSPECTIVES, AND CLINICAL IMPLICATIONS 68
Mediatori aminoacidici della retina 64
Neurosteroidogenic pathways toward retinal neurodegeneration and neuroprotection 64
Eye drops of Ch-Cx carrier silibinin inducing protection in a model of Age-related Macular Disease (AMD). 63
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. II Report 61
The neurosteroid pregnenolone sulfate contributes to neuronal cell death 59
A bicistronic vector to study the effect of CLN8/VAPA interaction on cell physiology and eventually the pathology of CLN8-associated NLC diseases 57
CRISPR/Cas9 "CLN8 null" towards a dysfunctional autophagy in CLN8-associated neuronal ceroid lipofuscinosis diseases-ePoster # 4774 56
Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina 55
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 55
Facts News & Views Organo Ufficiale della Società Italiana di NeuroPsicoFarmacologia. Numero Speciale 54
Interaction of alphaA-crystallin with beta-amyloid in diabetic retina: an emerging antifibrillogenesis activity. 53
Relazione finale progetto Studio della degenerazione retinica in corso di lipofuscinosi ceroidea neuronale (malattia di Batten) in topi MND , FIRB-MIUR / RBAU01E3SL_001, anno 2006 50
Expression of VAPB cleavage of products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis 49
NEUROSTEROIDOGENESIS IN RAT RETINAS 48
Topical application of choline-calix[4]arene nanocarrier of silibinin reduces retinal damage in a model of Age-Related Macular Disease. 48
Disfunzione autofagica precoce nella malattia da accumulo lisosomiale tipo ceroidolipofuscinosi associata al gene CLN8 46
CLN8 protein: a post-translation modification and subcellular distribution study for understanding CLN8 physiopathology 46
Neurosteroid synthesis: an early event in retinal neurodegeneration 44
The estrogenic retina: The potential contribution to healthy aging and age-related neurodegenerative diseases of the retina 44
NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES 43
Iron accumulation and retinal pathology: neuroprotection by diketopiperazines 43
Effect of uridine of GABA receptors. 42
CNR Environment and Health Inter-departmental Project: present knowledge and prospects for future research. 42
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. TELETHON Grant GGP16277 42
METHYL MERCURY ENHANCES TRITIUM LABELED DIAZEPAM BINDING IN DIFFERENT AREAS OF THE RAT BRAIN 41
Different early ER-stress responses in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 41
Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis 41
Studi di biodisponibilità della Silibinina strutturata in nanoparticelle per la terapia di patologie retiniche neurodegenerative 41
Neglected CLN8 protein function in the neuronal ceroid lipofuscinoses (NCLs). 40
HIPPOCRATES PON02_00355 Regione Sicilia - Sviluppo di Micro e Nano-Tecnologie e Sistemi Avanzati per la Salute dell'uomo. 40
Estrogen receptors in HAECs: neuronal differentiation and stemness. 40
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with Vesicle-Associated Membrane Protein-associated Protein A (VAPA), and genotype-phenotype correlations 40
Estrogen and androgen regulation of the small heat shock protein ±A-crystallin: New perspectives on sex steroid implication in age-related disorders associated with proteotoxic stress. 39
A potential interactome map of CLN8 protein involved in the late-infantile form of neuronal ceroid lipofuscinosis. 39
Effetti di nuove diketopiperazine in un modello in vivo di Degenerazione Maculare Senile 39
Human neuroblastoma SH-SY5Y cell line: Neurosteroid-producing cell line relying on cytoskeletal organization 38
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases 38
The role of autophagy in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 38
Does neurosteroidogenesis contribute to neuronal excitotoxicity? 37
Autophagy and mitophagy in the CLN8mnd mouse, a model of childhood neurodegenerative diseases 37
Low concentrations of silibinin and choline-calixarene or INU-C8-PEG carriers assembling silibinin promote antioxidant and antiapoptotic effects in neuronal and retinal epithelial cells. 37
Orphanet - Il portale delle malattie rare e dei farmaci orfani: The CLN8 variant late-infantile neuronal ceroid lipofuscinosis (CLN8-vLINCL): functional aspects of the CLN8 protein and characterization of the degenerative mechanisms . 36
An early impact of ER stress, inflammation and oxidative stress in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis 34
Sustained release of silibinin to the posterior segment of the eye by mucoadhesive NLC 34
Identification of an antigen related to the sea urchin RNA-binding protein LP54 in mammalian central nervous system. 32
CLN8 interactors: a possible function of the CLN8 protein in the lipid metabolism and autophagy 32
17b-estradiol synthesis in the adult male rat retina. 31
Tackling mechanisms of CLN8 mutations in neuronal ceroid lipofuscinosis (NCLs). 31
Retinopatia diabetica sperimentale: ruolo dei gangliosidi. 30
CAMP/PKA-linked phosphorylation and cytoskeletal organization are required for cholesterol transport and neurosteroid synthesis in neuroblastoma SH-SY5Y cells 30
Riunione Annuale CLNet 30
La patogenesi delle varianti CLN8 nelle ceroidolipofuscinosi. 29
Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis 29
The protective role of estrogen-receptor-beta in retinal excitotoxicity. 28
GAMMA-AMINOBUTYRIC-ACID TYPE-A BENZODIAZEPINE RECEPTORS REGULATE RAT RETINA NEUROSTEROIDOGENESIS 28
Modelli retinici per le nanotecnologie e il biomonitoraggio ambientale 27
Retinal oxidation and apoptosis in the motor neuron degeneration mouse, a model of neuronal ceroid lipofuscinosis 27
Structure specificity of ER stress in the CLN8-MND mouse model of the late-infantile neuronal ceroid lipofuscinosis. 26
Execution pathways of pregnenolone sulfate-induced retinal apoptosis 26
High vulnerability of estrogen-producing retinal cells to excitotoxic insult: downregulation of P450 aromatase activity 26
IN VIVO EFFECTS OF 17BETA-ESTRADIOL AND DHT ON THE RAT RETINA: A PROTEOMIC APPROACH 26
Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity 26
Structure specificity of ER stress in the Cln8-mnd mouse model of the late-infantile neuronal ceroid. 26
Prodotto l anticorpo anti-CLN8, proteina implicata in una patologia neurodegenerativa rara del bambino. 25
TARGETING TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND AMELIORATES RETINAL PATHOLOGY IN A TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE 25
Peripheral-type benzodiazepine receptor role in the regulation of steroid and neurosteroid biosynthesis 25
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse 25
Neurosteroidogenic pathways toward retina neurodegeneration or neuroprotection 25
PATHOGENIC MECHANISMS IN THE CLN8 FORM OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS. NEW INSIGHTS INTO THE VISUAL LOSS FROM THE CLN8mnd MOUSE MODEL 24
The protective role of Estrogen-Receptor-Beta in retinal excitotoxicity. 24
ER stress and inflammation, two interactive responses in neurodegenerative processes. 24
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration 24
CLN8 and VAPA, a possible protein-protein interaction at the ER for the regulation of lipid metabolism 24
DeadEndTM Colorimetric apoptosis detection system for the analysis of retinal apoptosis 24
Sistemi modello di patologie retiniche e neurodegenerative e strategie per la comprensione, la diagnosi e la terapia. 24
INTERACTION OF URIDINE WITH GAMMA AMINO BUTYRIC-ACID BINDING SITES IN CEREBELLAR MEMBRANES OF THE RAT 23
Functional analysis of L-3H Iysine binding to the rat retina. 23
A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-speci.c caspase-2 activation in the retinal cell death 23
Modulation of neurosteroidogenesis by NMDA receptors is an early event involved in acute excitotoxicity 23
Uridina e complesso recettoriale GABA Benzodiazepine ionoforo. 23
Retinal steroidogenic machinery: expression and activity of P450scc, P450c17, 3bHSD, P450aromatase 23
CLN8 and VAP-A, a possible protein-protein interaction at the ER for the regulation of lipid metabolism and with implication in neurodegenerative diseases. 23
TRITIATED L LYSINE BINDING TO RAT RETINAL MEMBRANE II. EFFECT OF KAINIC ACID D L-ALPHA AMINOADIPIC ACID IODOACETIC ACID AND MODIFICATION BY DARK-EXPOSURE 22
TRAIL and TRAIL neutralizing antibody in the retina and RPE/choroid of the 3xTg-AD mouse model of Alzheimer disease. 22
ENDOPLASMIC RETICULUM STRESS AND THE UNFOLDED PROTEIN RESPONSE IN THE Cln8mnd MOUSE MODEL OF NEURONAL CEROID LIPOFUSCINOSES (NCLS) 22
Orphanet - Il portale delle malattie rare e dei farmaci orfani: Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers . 22
Tumor necrosis factor-related apoptosis inducing ligand/glucocorticoid-induced TNF receptor ligand redundancy in neurodegenerative processes 22
Progetto Invecchiamento "PNR-CNR Aging Program 2012-2014 PI.P02 "Invecchiamento: Innovazioni tecnologiche e molecolari per un miglioramento della salute dell'anziano" 22
FUNCTIONAL CHARACTERIZATION OF THE NEURONAL CEROID LIPOFUSCINOSIS CLN8 PROTEIN: INSIGHTS FROM THE SPLIT-UBIQUITIN MEMBRANE-BASED YEAST TWO-HYBRID SYSTEM 21
Ruolo degli estrogeni nella neuroprotezione della retina 21
STRUCTURE SPECIFICITY OF ER STRESS IN THE CLN-MND MOUSE MODEL OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS 21
VAPB as a possible disease-modifier of ALS. 21
Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system 20
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. 20
Totale 4.088
Categoria #
all - tutte 14.538
article - articoli 4.922
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 817
Totale 20.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202431 0 0 0 0 0 0 0 0 17 3 5 6
2024/20252.485 14 9 162 120 635 62 29 71 121 151 598 513
2025/20262.352 209 400 342 575 637 128 61 0 0 0 0 0
Totale 4.868